Springs Rejuvenation Issued Joint Therapy Information
The clinic published educational materials detailing its stem cell and exosome joint wellness protocols.
Updated on Oct. 12, 2026 in Arthritis
Live Poll
Would you consider undergoing an experimental medical procedure that has not yet received FDA approval?
Springs Rejuvenation has released an educational article focused on stem cell and exosome joint therapy. The clinic aims to provide information on minimally invasive alternatives to surgical joint interventions.
Why it matters
The educational release highlights alternative approaches to managing joint wellness. Patients are increasingly looking for minimally invasive options as potential substitutes for traditional surgical procedures.
Springs Rejuvenation operates clinics at 5 locations nationwide and utilizes a 0.9mm micro FUE instrument during its joint wellness protocols. While the formulas are produced in an FDA-approved lab, the therapy itself is not FDA-approved.
The players
Springs Rejuvenation
This organization operates a network of clinics specializing in joint wellness and stem cell therapy.
The details
The facility employs physician-supervised care to administer its Stem 3 Protocol, which combines stem cells and exosomes. This procedure is designed as a minimally invasive option for individuals seeking alternatives to standard surgical joint interventions.
Timeline
A study on exosome-based biologics was published in 2021.
The educational article was released on October 11, 2026.
Health Landscape
This educational initiative follows the framework established by the 2021 Journal of Translational Medicine study on exosome-based biologics. The clinic's focus on these applications reflects the broader evolution of research into non-surgical musculoskeletal interventions.
Patients considering these therapies should be aware that while the formula is produced in an FDA-approved lab, the treatment itself is not FDA-approved. Individuals interested in the protocol can access physician-supervised care at any of the clinic's five regional locations.
The takeaway
Patients should conduct thorough research and consult with medical professionals when evaluating minimally invasive joint therapies. Understanding the regulatory status of specific treatments is a critical step in making informed healthcare decisions.
Further reading
For more information on joint health, see our Arthritis section.
Source note: This article includes information reported by Trinidad Express Newspapers.
Live Poll
Would you consider undergoing an experimental medical procedure that has not yet received FDA approval?
